NDC codes

401334 NDC codes with hospital pricing data in the network.

• NDC 00409318203 — AVYCAZ 2.5 (2-0.5) G IV SOLR (84 hospitals, 2,108–3,566 samples)
• NDC 63323048703 — LIDOCAINE-EPINEPHRINE (PF) 1 %-1:200,000 INJECTION SOLUTION (48 hospitals, 2,108–3,566 samples)
• NDC 70121171909 — MAGNESIUM SULFATE 2 GM/50ML IV SOLN (144 hospitals, 1,964–3,566 samples)
• NDC 66975042551 — LIDOCAINE-EPINEPHRINE 2 %-1:100000 INJ 1.7ML CARTRIDGE (DENTAL USE ONLY) (45 hospitals, 2,108–3,566 samples)
• NDC 00409318231 — LIDOCAINE 20 MG/ML (2 %)-EPINEPHRINE 1:100,000 INJECTION SOLUTION (45 hospitals, 2,108–3,566 samples)
• NDC 43128010515 — LIDOCAINE 2 %-EPINEPHRINE BITARTRATE 1:100,000 INJECTION CARTRIDGE (23 hospitals, 2,108–3,566 samples)
• NDC 00069-4547-01 — dexAMETHasone Sodium Phosphate (20 hospitals, 2,843–3,563 samples)
• NDC 68382039504 — RIBAVIRIN 6 G IN SOLR (22 hospitals, 3,319–3,562 samples)
• NDC 67457055400 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (128 hospitals, 1,536–3,561 samples)
• NDC 00781321046 — cefTRIAXone 10,000 mg INJ Powder (Bulk Package) (35 hospitals, 2,498–3,560 samples)
• NDC 00143-9330-01 — CALCIUM CHLORIDE 100 MG/ML (10 %) IV SYRG (41 hospitals, 3,298–3,559 samples)
• NDC 00409-6509-49 — VANCOMYCIN HCL 5 G/100ML IV (WET SOLR VIAL) (34 hospitals, 3,556 samples)
• NDC 00000-0022-28 — NOREPINEPHRINE BITARTRATE-NACL 4 MG/250 ML (16 MCG/ML) IV SOLN (3 hospitals, 3,556 samples)
• NDC 00000-0009-61 — VANCOMYCIN HCL/NSS 10 MG/ML (SPDIL) INJ IVPB (1 hospital, 3,556 samples)
• NDC 00000-0020-35 — VANCOMYCIN 2 G IN SODIUM CHLORIDE 0.9% STOCK 570 ML BAG (1 hospital, 3,556 samples)
• NDC 00000-0020-33 — VANCOMYCIN 1 G IN SODIUM CHLORIDE 0.9% STOCK 285 ML BAG (2 hospitals, 3,556 samples)
• NDC 43066001610 — CARDENE IV 40-0.83 MG/200ML-% IV SOLN (320 hospitals, 1,035–3,555 samples)
• NDC 83634050081 — magnesium sulfate 2 g/50 mL-sterile water, RTU [CITY] (158 hospitals, 1,701–3,555 samples)
• NDC 70004041159 — midazolam 1 mg/mL Soln 100 mL Bag (56 hospitals, 1,573–3,553 samples)
• NDC 23155-0196-31 — ONDANSETRON 4 MG/2 ML SOLN 2 ML VIAL (11 hospitals, 2,418–3,552 samples)
• NDC 63323-0738-09 — PEPCID 40MG/4ML VIAL (28 hospitals, 3,551 samples)
• NDC 00000-0005-31 — FAMOTIDINE PF/NSS 2 MG/ML IV SOLN (SPDIL) EXTEMP INJ (2 hospitals, 3,551 samples)
• NDC 00781329091 — CLINDAMYCIN PHOSPHATE IN D5W 900 MG/50ML IV SOLN (132 hospitals, 940–3,550 samples)
• NDC 63323057905 — SINCALIDE 5 MCG IJ SOLR (121 hospitals, 1,696–3,550 samples)
• NDC 00187433005 — ISOPROTERENOL 0.2 MG/ML INJECTION SOLUTION (72 hospitals, 3,514–3,550 samples)
• NDC 00409672723 — magnesium sulfate 1 gram/100 mL Pgbk 100 mL BAG (234 hospitals, 1,712–3,548 samples)
• NDC 00054-3505-47 — lidocaine 4% topical soln. - 50 mL btl. (157 hospitals, 2,943–3,537 samples)
• NDC 63323006410 — magnesium sulfate 40.6 mEq/10 mL Injection (156 hospitals, 1,887–3,534 samples)
• NDC 63739051910 — PREDNISONE 10 MG TABLET (109 hospitals, 939–3,531 samples)
• NDC 00121075908 — prednisoLONE 3 mg/mL ORAL Syringe (Alcohol Free) (270 hospitals, 839–3,530 samples)
• NDC 69238212209 — KETOCONAZOLE 2 % EX SHAM (59 hospitals, 839–3,530 samples)
• NDC 00004-1962-01 — INJECTION, CEFTRIAXONE SODIUM, PER 250 MG (23 hospitals, 2,682–3,528 samples)
• NDC 83634060351 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (26 hospitals, 2,384–3,518 samples)
• NDC 70004022940 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (35 hospitals, 2,194–3,517 samples)
• NDC 73702020203 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (27 hospitals, 2,194–3,517 samples)
• NDC 641608025 — ondansetron 4 mg/2 mL Soln-Inj (77 hospitals, 3,029–3,515 samples)
• NDC 00338008503 — DEXTROSE 5 % AND 0.45 % NACL IV BOLUS (185 hospitals, 2,217–3,513 samples)
• NDC 00338171540 — Magnesium Sulfate: 40 Bag In 1 Carton (0338-1715-40) / 100 Ml In 1 Bag (158 hospitals, 1,531–3,511 samples)
• NDC 00409-6637-14 — SODIUM BICARBONATE 8.4 % (1 MEQ/ML) INTRAVENOUS SYRINGE (57 hospitals, 2,682–3,510 samples)
• NDC 51079-0991-20 — HALOPERIDOL LACTATE 5 MG/ML INJECTION SOLUTION (63 hospitals, 3,346–3,508 samples)
• NDC 50268-0759-11 — TIZANIDINE HCL 2 MG PO TABS (48 hospitals, 3,346–3,508 samples)
• NDC 73177010201 — FENTANYL (PF) 10 MCG/ML NEONATAL DILUTION INJECTION (55 hospitals, 2,235–3,504 samples)
• NDC 63323046431 — SENSORCAINE-MPF 0.25 % (2.5 MG/ML) INJECTION SOLUTION (126 hospitals, 2,089–3,502 samples)
• NDC 50242004413 — ALTEPLASE RECOM 1MG (405 hospitals, 828–3,501 samples)
• NDC 00517-4605-25 — GLYCOPYRROLATE 0.2 MG/ML INJECTION SOLN (41 hospitals, 3,455–3,500 samples)
• NDC 17478054050 — 17478-0540-50 - HYDROmorphone 10 mg/mL Soln (176 hospitals, 1,707–3,498 samples)
• NDC 00052-0450-15 — Rocuronium 10 mg/mL Inje* (28 hospitals, 2,680–3,490 samples)
• NDC 00074-7101-67 — UNCLASSIFIED DRUGS (19 hospitals, 2,680–3,490 samples)
• NDC 00186-0654-01 — UNCLASSIFIED DRUGS (19 hospitals, 2,680–3,490 samples)
• NDC 00409-6625-02 — SODIUM BICARBONATE (25 hospitals, 2,680–3,490 samples)